350 related articles for article (PubMed ID: 14532768)
21. [Immunocytologic detection of disseminated tumor cells in the peritoneal cavity and bone marrow in patients with pancreatic carcinoma].
Juhl H; Kalthoff H; Krüger U; Schott A; Schreiber HW; Henne-Bruns D; Kremer B
Chirurg; 1994 Dec; 65(12):1111-5. PubMed ID: 7851144
[TBL] [Abstract][Full Text] [Related]
22. Bone-marrow microinvolvement in non-small cell lung cancer is not a reliable indicator of tumour recurrence and prognosis.
Hsu CP SL; Chen CY; Kwang PC; Miao J; Hsia JY; Shai SE
Eur J Surg Oncol; 2000 Nov; 26(7):691-5. PubMed ID: 11078616
[TBL] [Abstract][Full Text] [Related]
23. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.
Zigeuner R; Ratschek M; Rehak P; Schips L; Langner C
Urology; 2004 Apr; 63(4):651-5. PubMed ID: 15072872
[TBL] [Abstract][Full Text] [Related]
24. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
Tamas EF; Epstein JI
Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
[TBL] [Abstract][Full Text] [Related]
25. Spectrum of cytokeratin-positive cells in the bone marrows of colorectal carcinoma patients.
Shetye JD; Liljefors ML; Emdin SO; Frödin JE; Strigård K; Mellstedt HT; Porwit A
Anticancer Res; 2004; 24(4):2375-83. PubMed ID: 15330187
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.
Clark PE; Veys JA; Eskridge MR; Woodruff RD; Hall MC
Urol Oncol; 2005; 23(5):328-32. PubMed ID: 16144666
[TBL] [Abstract][Full Text] [Related]
27. A relevant immunomagnetic assay to detect and characterize epithelial cell adhesion molecule-positive cells in bone marrow from patients with breast carcinoma: immunomagnetic purification of micrometastases.
Choesmel V; Anract P; Høifødt H; Thiery JP; Blin N
Cancer; 2004 Aug; 101(4):693-703. PubMed ID: 15305398
[TBL] [Abstract][Full Text] [Related]
28. Immunocytochemical detection of isolated epithelial cells in bone marrow: non-specific staining and contribution by plasma cells directly reactive to alkaline phosphatase.
Borgen E; Beiske K; Trachsel S; Nesland JM; Kvalheim G; Herstad TK; Schlichting E; Qvist H; Naume B
J Pathol; 1998 Aug; 185(4):427-34. PubMed ID: 9828843
[TBL] [Abstract][Full Text] [Related]
29. Prognostic impact of tumor size on pT2 renal cell carcinoma: an international multicenter experience.
Klatte T; Patard JJ; Goel RH; Kleid MD; Guille F; Lobel B; Abbou CC; De La Taille A; Tostain J; Cindolo L; Altieri V; Ficarra V; Artibani W; Prayer-Galetti T; Allhoff EP; Schips L; Zigeuner R; Figlin RA; Kabbinavar FF; Pantuck AJ; Belldegrun AS; Lam JS
J Urol; 2007 Jul; 178(1):35-40; discussion 40. PubMed ID: 17521678
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of bone marrow microinvolvement in nonsmall cell lung carcinoma.
Hsu CP; Shai SE; Hsia JY; Chen CY
Cancer; 2004 Feb; 100(4):794-800. PubMed ID: 14770436
[TBL] [Abstract][Full Text] [Related]
31. Significance of macroscopic tumor necrosis as a prognostic indicator for renal cell carcinoma.
Lee SE; Byun SS; Oh JK; Lee SC; Chang IH; Choe G; Hong SK
J Urol; 2006 Oct; 176(4 Pt 1):1332-7; discussion 1337-8. PubMed ID: 16952624
[TBL] [Abstract][Full Text] [Related]
32. Urokinase plasminogen activator receptor (uPA-R): one potential characteristic of metastatic phenotypes in minimal residual tumor disease.
Allgayer H; Heiss MM; Riesenberg R; Grützner KU; Tarabichi A; Babic R; Schildberg FW
Cancer Res; 1997 Apr; 57(7):1394-9. PubMed ID: 9102229
[TBL] [Abstract][Full Text] [Related]
33. Detection of circulating tumor cells from renal carcinoma patients: experiences of a two-center study.
Blümke K; Bilkenroth U; Schmidt U; Melchior A; Füssel S; Bartel F; Heynemann H; Fornara P; Taubert H; Wirth MP; Meye A
Oncol Rep; 2005 Oct; 14(4):895-9. PubMed ID: 16142348
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma.
Motzer RJ; Bacik J; Schwartz LH; Reuter V; Russo P; Marion S; Mazumdar M
J Clin Oncol; 2004 Feb; 22(3):454-63. PubMed ID: 14752067
[TBL] [Abstract][Full Text] [Related]
35. Microscopic tumor cell dissemination in gastric cancer.
Jonas S; Weinrich M; Tullius SG; Al-Abadi H; Steinbrich R; Radke C; Klupp J; Neuhaus P
Surg Today; 2004; 34(2):101-6. PubMed ID: 14745607
[TBL] [Abstract][Full Text] [Related]
36. Detection of cytokeratin-positive cells in the bone marrow of breast cancer patients undergoing adjuvant therapy.
Becker S; Becker-Pergola G; Wallwiener D; Solomayer EF; Fehm T
Breast Cancer Res Treat; 2006 May; 97(1):91-6. PubMed ID: 16319975
[TBL] [Abstract][Full Text] [Related]
37. Microscopic venous invasion in renal cell carcinoma as a predictor of recurrence after radical surgery.
Ishimura T; Sakai I; Hara I; Eto H; Miyake H
Int J Urol; 2004 May; 11(5):264-8. PubMed ID: 15147540
[TBL] [Abstract][Full Text] [Related]
38. Sporadic renal cell carcinoma in young and elderly patients: are there different clinicopathological features and disease specific survival rates?
Denzinger S; Otto W; Burger M; Hammerschmied C; Junker K; Hartmann A; Wieland WF; Walter B
World J Surg Oncol; 2007 Feb; 5():16. PubMed ID: 17280613
[TBL] [Abstract][Full Text] [Related]
39. The role of wide-spectrum cytokeratin staining of the bone marrow cores in patients with ductal carcinoma of the breast.
Dunphy CH
Mod Pathol; 1996 Oct; 9(10):955-8. PubMed ID: 9005447
[TBL] [Abstract][Full Text] [Related]
40. [The prognostic significance of tumor cell detection in bone marrow of patients with breast cancer].
Diel IJ; Kaufmann M; Costa SD; Kaul S; Krempien B; Goerner R; Bastert G
Geburtshilfe Frauenheilkd; 1990 Dec; 50(12):923-8. PubMed ID: 1707840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
